Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Anguita

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Journal of Clinical Medicine|March 10, 2022
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline CharacteristicsJuan F Delgado-Jiménez, Javier Segovia-Cubero, Luis Almenar-Bonet, et al.
European Heart Journal|December 25, 2004
Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortalityIgnasi Anguera, Jose M Miro, Isidre Vilacosta, et al.
The American Journal of Cardiology|October 24, 2006
Periannular complications in infective endocarditis involving native aortic valvesIgnasi Anguera, Jose M Miro, Artur Evangelista, et al.
European Journal of Heart Failure|May 30, 2025
Insights into the European heart failure epidemiologyPetar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Revista Espanola De Cardiologia (English Ed.)|April 25, 2026
Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trialSergio Raposeiras-Roubín, Manuel Anguita, Roberto Latini, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
Journal of Clinical Medicine|October 27, 2022
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language ProcessingCarlos González-Juanatey, Manuel Anguita-Sánchez, Vivencio Barrios, et al.
The American Journal of Cardiology|October 24, 2006
Periannular complications in infective endocarditis involving prosthetic aortic valvesIgnasi Anguera, Jose M Miro, Jose Alberto San Roman, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
Revista Espanola De Cardiologia (English Ed.)|November 22, 2011
New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrillationManuel Anguita, Fernando Worner, Pere Domenech, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Journal of Clinical Medicine|March 10, 2022
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline CharacteristicsJuan F Delgado-Jiménez, Javier Segovia-Cubero, Luis Almenar-Bonet, et al.
European Heart Journal|December 25, 2004
Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortalityIgnasi Anguera, Jose M Miro, Isidre Vilacosta, et al.
The American Journal of Cardiology|October 24, 2006
Periannular complications in infective endocarditis involving native aortic valvesIgnasi Anguera, Jose M Miro, Artur Evangelista, et al.
European Journal of Heart Failure|May 30, 2025
Insights into the European heart failure epidemiologyPetar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Revista Espanola De Cardiologia (English Ed.)|April 25, 2026
Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trialSergio Raposeiras-Roubín, Manuel Anguita, Roberto Latini, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trialXavier Rossello, Pedro L Sánchez, Ruth Owen, et al.
Journal of Clinical Medicine|October 27, 2022
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language ProcessingCarlos González-Juanatey, Manuel Anguita-Sánchez, Vivencio Barrios, et al.
The American Journal of Cardiology|October 24, 2006
Periannular complications in infective endocarditis involving prosthetic aortic valvesIgnasi Anguera, Jose M Miro, Jose Alberto San Roman, et al.
European Heart Journal|August 30, 2025
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trialXavier Rossello, Alberto Dominguez-Rodriguez, Roberto Latini, et al.
Revista Espanola De Cardiologia (English Ed.)|November 22, 2011
New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrillationManuel Anguita, Fernando Worner, Pere Domenech, et al.
Pageof 27